Core Viewpoint - The company, Far East Holdings (000626.SZ), anticipates a net loss of 60 million to 120 million yuan for the fiscal year 2025, compared to a loss of 301.76 million yuan in the same period last year [1] Financial Performance - The expected net loss for 2025 is between 60 million and 120 million yuan, while the adjusted net loss (excluding non-recurring items) is projected to be between 120 million and 240 million yuan, compared to 554.81 million yuan in the previous year [1] - The primary reason for the losses is the impairment testing of goodwill related to investment acquisitions, influenced by macroeconomic slowdown and underperformance of acquired assets [1] Goodwill Impairment - The company plans to recognize a goodwill impairment provision of 75 million to 150 million yuan based on cautious judgment regarding the existence of impairment signs [1] Business Model Impact - The company employs a business model that combines spot and futures trading in the commodity trading sector, leading to significant differences in net profit before and after excluding non-recurring items, although this does not affect the company's actual operational capabilities [1]

Core Viewpoint - The company, Dianhun Network, is facing significant financial challenges, including a projected net loss for 2025 and a decline in revenue and profitability over recent years [2][3]. Group 1: Shareholder and Executive Share Reduction - On January 28, 2026, Dianhun Network disclosed the results of share reductions by its shareholders and executives, with a total of 3.6337 million shares sold [1]. - Among the executives, Yu Xiaoliang, a major shareholder, accounted for over 90% of the total reduction, although he did not fully execute his planned reduction of 3.9181 million shares [1]. - The company did not provide reasons for the share reductions, only stating that the reduction plan period had expired [1]. Group 2: Financial Performance and Forecast - On January 20, 2026, the company announced an expected net loss of between 160 million yuan and 230 million yuan for 2025, a stark contrast to a profit of 30.58 million yuan in the previous year [2]. - The decline in revenue is attributed to decreased game recharge flow from its wholly-owned subsidiary, Xiamen Youdong Network Technology Co., Ltd., and significant impairment of goodwill [2]. - Historical performance shows a continuous decline in revenue from 1.024 billion yuan in 2020 to 550 million yuan in 2024, a cumulative drop of 46.29%, and a net profit decrease of 92.2% from 395 million yuan to 31 million yuan [2]. - The core product, the "Dream Three Kingdoms" series, is experiencing stagnation in user growth and revenue decline, with a 33.72% year-on-year drop in revenue for the first half of 2025 [2].

Group 1 - The company expects a positive net profit for the year 2025, indicating a turnaround from previous losses [1] - The performance improvement is primarily driven by the smart equipment and lithium battery recycling sectors, with significant growth in overseas projects and a reduction in losses for the lithium battery recycling business [2] - The smart equipment business has a strong order reserve, with notable growth in both domestic and international markets, leading to stable revenue and profit growth [2] Group 2 - The lithium battery recycling business faced challenges due to unstable raw material supply, but improved capacity utilization in Q4 and rising cobalt prices have led to a significant reduction in losses [2] - The recycling equipment business has seen declining revenue due to a depressed scrap steel market, resulting in substantial losses [2] - The company is assessing goodwill impairment related to its acquisition of Jiangxi Tianqi Jintai Ge Cobalt Co., with indications of impairment based on market conditions and operational performance [3] Group 3 - The company anticipates recognizing an investment loss of between 25 million to 30 million yuan from its stake in Wuxi Youqi Intelligent Technology Co., which is still in the R&D phase [3] - Non-operating income for the reporting period is estimated to be around 130 million to 140 million yuan, primarily from the disposal of equity in associated companies and long-term assets [3] - The performance forecast is based on preliminary estimates and has not been audited, with final figures to be disclosed in the 2025 annual report [4]

Group 1 - The core viewpoint of the article indicates that the company's main business is under pressure due to the macroeconomic environment, with the retail department store industry still in a bottoming phase, leading to a decline in net profit [2] - The company plans to recognize goodwill impairment of approximately 53.88 million to 71.84 million yuan and impairment of investment properties of about 184.25 million to 245.66 million yuan due to declining operating conditions and rental levels [2] - The company's performance has been declining consistently, with revenue dropping from 4.168 billion yuan in 2021 to 2.716 billion yuan in 2024, and net profit falling from 409 million yuan in 2021 to only 37.15 million yuan in 2024, a decrease of nearly 90% over four years [2] Group 2 - Despite the continuous decline in performance, losses are still considered rare for the company [4]

Group 1 - The company expects a net profit attributable to shareholders of 180 million to 218 million yuan for 2025, representing a decline of 66.21% to 59.07% compared to the same period last year [1] - The net profit after deducting non-recurring gains and losses is projected to be between 170.93 million and 210.93 million yuan, reflecting a decrease of 67.16% to 59.48% year-on-year [1] - The company's subsidiary, Meichuang, is facing significant operational challenges due to the impact of medical industry policies, increased competition, and pressure on both volume and pricing [1] Group 2 - The company plans to recognize an impairment provision for goodwill of approximately 180 million yuan due to signs of impairment in related asset groups, following a cautious principle [1] - As of the date of this announcement, the goodwill impairment testing is still ongoing, and the final amount of the impairment provision will be determined based on evaluations and audits by qualified assessment and auditing institutions [1]

Core Viewpoint - The company Huaping Co., Ltd. (300074.SZ) expects a loss of between 161.38 million to 225.13 million yuan for the year 2025, with a non-recurring loss estimated between 165.72 million to 231.18 million yuan [1] Financial Performance - The company has engaged an evaluation agency to assess the goodwill arising from its acquisition of Zhengzhou Xinyi Hua Medical Technology Co., Ltd. and Zhengzhou Xinyi Hua Information Technology Co., Ltd. [1] - The assessment indicates signs of impairment for the goodwill associated with these acquisitions [1] Impairment Provision - The company plans to recognize an impairment provision for the consolidated goodwill related to the asset groups of Xinyi Hua Medical and Xinyi Hua Information, estimated between 53.36 million to 69.35 million yuan [1] - The final amount of the impairment provision will depend on the formal goodwill impairment testing report from the evaluation agency and the audit results from the accounting firm [1]

报告期内，公司全资子公司 Polymer Technology Systems,Inc.（以下简称PTS 公司）经营业绩未达预期。 根据《企业会计准则第8 号-资产减值》及相关会计政策规定，公司将在 2025 年度报告中对商誉进行系 统性减值测试。结合PTS公司实际经营状况、行业市场变化和预期经营情况，经公司根据谨慎性原则初 步判断，对收购 PTS 公司所形成的商誉计提部分减值，预计本期计提的商誉减值总额为 13,000 万元至 17,000 万元。最终商誉减值准备计提的金额将由公司聘请的具备证券期货从业资格的评估机构及审计机 构进行评估和审计后确定。 格隆汇1月28日丨三诺生物(300298.SZ)公布，预计2025年归属于上市公司股东的净利润8,500万元至 12,750万元，比上年同期下降73.95%至60.92%，扣除非经常性损益后的净利润4,500万元至6,750万元， 比上年同期下降84.73%至77.09%。 ...

报告期内，公司无人机业务收入整体实现增长，但结构发生变化，其中：无人机海外业务景气程度维持 高位，公司成功推动多个海外项目对接，但受订单签订安排的滞后性影响，期内海外收入同比有所减 少；无人机国内市场订单集中落地，用户对公司产品认可度不断提升，业务收入实现同比增长；公司通 过高效的生产与供应链管理，圆满完成全年产品交付任务，无人机产能利用率处于历史高位。此外，公 司持续处置低效资产，实现台州部分土地厂房资产成功转让，预计对公司当期利润产生积极影响。 格隆汇1月28日丨航天彩虹(002389.SZ)发布2025年度业绩预告，预计2025年度归属于上市公司股东的净 利润2500万元–3100万元，比上年同期下降64.84%-71.65%；扣非净亏损5800万元–6500万元，上年同期 亏损724万元。 公司新材料业务受行业供需格局影响，终端需求和产品价格呈现较大压力，导致新材料业务经营持续承 压，叠加商誉减值影响，预计对公司整体利润水平造成不利影响。另外，因美元贬值，汇兑损益也对公 司利润水平产生较大负面影响。 ...

智通财经APP讯，韩建河山(603616.SH)发布2025年年度业绩预亏公告，预计2025年度实现归属于母公 司所有者的净利润为-1,200万元到-800万元。 2025年度公司主营业务预应力钢筒混凝土管(PCCP)销售合同按照合同约定正常履约且订单稳定交付， 但公司混凝土外加剂业务受北京及其周边混凝土市场的影响收入较上年度有所下滑，公司混凝土外加剂 业务系由子公司河北合众建材有限公司(以下简称"合众建材")实施，2025年度公司将根据《企业会计准 则第8号-资产减值》《会计监管风险提示第8号—商誉减值》及公司会计政策等相关规定，在2025年度 报告中对商誉及各项资产进行减值测试，拟对与子公司合众建材资产组组合产生的12,160.71万元商誉计 提减值，预计本期计提减值商誉约900万元，以前年度已计提11,252.26万元。最终减值准备计提的金额 将由公司聘请的评估机构及审计机构进行评估和审计后确定。 2025年度公司环保业务经营亏损，公司环保业务系由子公司秦皇岛市清青环保设备有限公司(以下简 称"清青环保")实施，其2025年度在手订单实施不足且固定成本支出持续发生、大额计提信用减值损 失，公司子公司清青 ...

证券之星消息，华平股份发布业绩预告，预计2025年全年归属净利润亏损1.61亿元至2.25亿元。 公告中解释本次业绩变动的原因为： 1.报告期末，公司聘请了评估机构，对公司收购郑州新益华医学科技有限公司、郑州新益华信息科技有 限公司（以下简称"新益华医学"、"新益华信息"）所形成的商誉进行了初步评估和测算。结合行业发展 环境、市场趋势及实际经营状况等综合因素分析，判断新益华医学和新益华信息所形成的商誉出现减值 迹象。为更加客观、公正地反映公司的财务状况和资产价值，公司根据财政部《企业会计准则第8号— 资产减值》、中国证监会《会计监管风险提示第8号—商誉减值》及公司内部政策等相关规定，本着谨 慎性原则，预计对新益华医学和新益华信息资产组所形成的合并商誉计提减值准备金额为5,336万元至 6,935万元之间。最终计提商誉减值准备金额将以评估机构正式出具的商誉减值测试评估报告及会计师 事务所审计结果为准。2.报告期末，公司根据财政部《企业会计准则第8号—资产减值》，按照谨慎性 华平信息技术股份有限公司 公告 3.报告期内，受宏观需求波动与行业竞争加剧叠加影响，公司订单释放节奏放缓，收入规模同比收窄； 同时，在地方财 ...